• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Merck defends antibiotic`s approval from 2019

    ENDPTS

    FDA approvals roundup: Recarbrio

    RAPS

    US FDA approves Recarbrio to treat hospital-acquired bacterial pneumonia

    PHARMABIZ

    FDA Approves Merck’s (imipenem, cilastatin, and relebactam) for the Treatment

    MERCK

    Results of Ph 3 Trial Evaluating the Efficacy and Safety of Merck’s RECARBRIO™

    BUSINESSWIRE

    Results of Ph3 Trial Evaluating the Efficacy and Safety of Merck’s RECARBRIO™

    BUSINESSWIRE

    EMA’s Meeting highlights from CHMP) recommended five medicines for approval

    EMA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.